Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Eagle Pharmaceuticals Inc. (EGRX)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Hudson Executive Capital

Douglas Braunstein And James Woolery 

811,777 $45,200 -17% 4.35%
2. 1,300,000 $72,384 +25% 3%
3.
PDT Partners

Peter Muller

55,100 $3,068 -1% 0.18%
4. 5,308 $296 -48% 0.17%
5.
Algert Coldiron Investors

Peter Algert And Kevin Coldiron

5,023 $280 -74% 0.1%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$55.45 350 Officer 700 2017-08-16 Filing
$50.09 1,584 Director 971,000 2017-08-09 Filing
$49.21 15,206 Director 969,416 2017-08-09 Filing
$48.06 3,610 Director 954,210 2017-08-09 Filing
$71.49 350 Officer 350 2017-06-12 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$62.61 1,600 Director 760,324 2019-10-18 Filing
$62.58 13,842 Director 761,924 2019-10-17 Filing
$62.50 102 Director 775,766 2019-10-16 Filing
$62.63 3,909 Director 775,868 2019-10-15 Filing
$60.39 16,300 Director 779,777 2019-10-11 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 154,654 $8,749 0.93%
2. 91,350 $5,168 0.1%
3. 247 $14 0.01%
4. 11,600 $656 0%
5. 0 $0 0%
News See All